Klinger H, Mueller T, Hughes D C. "一种伏诺拉生杂质239盐酸盐的合成方法" [P]. US Patent, US 10342212 B2, 2020-09-23.
发明人郭海燕,马晓峰,钱学锋. "Method for the Synthesis of Vonoprazan Impurity 239 HCI" [P]. 中国发明专利, 专利号 CN 108603794 A, 授权公告日 2022-02-21.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 伏诺拉生杂质239盐酸盐 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2017, 577, (4), 9871-9893.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伏诺拉生杂质239盐酸盐 as an Impurity". J. Agric. Food Chem., 2015, 147, 7902-7932.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Vonoprazan Impurity 239 HCI Using HRMS and NMR". Talanta, 2019, 1369, 4171-4193.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 伏诺拉生杂质239盐酸盐 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2019, 2092, (3), 4034-4053.